Mark Lee
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Genetic factors in colorectal cancer 9
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Stefanie S. Jeffrey (3 shared papers)Michail Ignatiadis (1 shared paper)Richard D. Klausner (1 shared paper)Alexander M. Aravanis (1 shared paper)Kevin Struhl (2 shared papers)Frederick L. Baehner (2 shared papers)Kelly Handley (1 shared paper)Richard Gray (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Palliative Medicine (3 papers)Oncotarget (3 papers)Blood (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mark Lee
52 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 625
- Oncology 548
- Pathology and Forensic Medicine 245
- Otorhinolaryngology 55
- Pulmonary and Respiratory Medicine 256
Countries citing papers authored by Mark Lee
This map shows the geographic impact of Mark Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lee more than expected).
Fields of papers citing papers by Mark Lee
This network shows the impact of papers produced by Mark Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lee. The network helps show where Mark Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 288 | |
| 2 | 2011 | 259 | |
| 3 | 2017 | 254 | |
| 4 | 2023 | 84 | |
| 5 | 2014 | 77 | |
| 6 | 2016 | 72 | |
| 7 | 2010 | 58 | |
| 8 | 1995 | 57 | |
| 9 | 2009 | 38 | |
| 10 | 1997 | 36 | |
| 11 | 2009 | 34 | |
| 12 | 2022 | 34 | |
| 13 | 2001 | 33 | |
| 14 | 2020 | 31 | |
| 15 | 2004 | 28 | |
| 16 | 2023 | 26 | |
| 17 | 2016 | 25 | |
| 18 | 2019 | 24 | |
| 19 | 2016 | 24 | |
| 20 | 1988 | 24 |
About Mark Lee
Mark Lee is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Cancer Research, Neurology and Oncology, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (9 papers), Cancer Genomics and Diagnostics (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Dermatology and Skin Diseases (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (625 citations), Oncology (548 citations), Pathology and Forensic Medicine (245 citations), Otorhinolaryngology (55 citations) and Pulmonary and Respiratory Medicine (256 citations). Mark Lee has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Stefanie S. Jeffrey, Michail Ignatiadis, Richard D. Klausner, Alexander M. Aravanis, Kevin Struhl, Frederick L. Baehner, Kelly Handley, Richard Gray, Steven Shak and Kim M. Clark-Langone. Their work appears in journals such as Journal of Clinical Oncology, Palliative Medicine, Oncotarget, Blood and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.